Buchumschlag

Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Qing Wen, Ting Sun, Jia Chen, Yang Li, Xiaofan Liu, Huiyuan Li, Rongfeng Fu, Wei Liu, Feng Xue, Mankai Ju, Huan Dong, Xinyue Dai, Wentian Wang, Ying Chi, Renchi Yang, Yunfei Chen, Lei Zhang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	British Journal of Haematology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Kabuki syndrome complicated by severe immune thrombocytopenia and autoimmune thyroiditis: Identification of a novel pathogenic mutation
von: Xinmiao Qu, et al.
Veröffentlicht: (2024)

Comprehensive analysis and prediction model of mitophagy and ferroptosis in primary immune thrombocytopenia
von: Jiani Mo, et al.
Veröffentlicht: (2024)

Longitudinal evaluation of adverse events due to steroid use in primary immune thrombocytopenia: A population‐based study
von: Jiaan‐Der Wang, et al.
Veröffentlicht: (2024)

Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial
von: Qi Liu, et al.
Veröffentlicht: (2025)

Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia
von: Tian‐shu Yu, et al.
Veröffentlicht: (2025)

Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
von: Ju Li, et al.
Veröffentlicht: (2024)

Targeted proteomics profiling reveals valuable biomarkers in the diagnosis of primary immune thrombocytopaenia
von: Yizhi Jiang, et al.
Veröffentlicht: (2024)

Long‐term efficacy and safety of hetrombopag in paediatric patients with immune thrombocytopenia
von: Jin‐Hua Wang, et al.
Veröffentlicht: (2026)

COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia—Response
von: Xiang Liu, et al.
Veröffentlicht: (2024)

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia
von: Zhenyu Liu, et al.
Veröffentlicht: (2026)

Short‐ and long‐term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia
von: Boris Sorin, et al.
Veröffentlicht: (2026)

Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry
von: Guillaume Moulis, et al.
Veröffentlicht: (2024)

Feasibility of plasma proteomics in patients with immune thrombocytopenia
von: Rick Kapur
Veröffentlicht: (2024)

Service evaluation of R90 bleeding and platelet disorders gene panel in thrombocytopenia cases
von: G. Gurumurthy, et al.
Veröffentlicht: (2024)

Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
von: Zhifa Wang, et al.
Veröffentlicht: (2024)

Echinococcus granulosus antigen B regulates T‐cell function through inhibition of signal transducer and activator of transcription 3 in experimental immune thrombocytopenia
von: Yingbin Yue, et al.
Veröffentlicht: (2025)

Chemotherapy‐induced thrombocytopenia: modern diagnosis and treatment
von: Andrew B. Song, et al.
Veröffentlicht: (2025)

Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study
von: LiQin Cao, et al.
Veröffentlicht: (2026)

CD19 chimeric antigen receptor‐T cell therapy in murine immune thrombocytopenia
von: Fengjiao Han, et al.
Veröffentlicht: (2025)

Anti‐ CD38 therapy in immune thrombocytopenia ( ITP )
von: Waleed Ghanima, et al.
Veröffentlicht: (2026)

Predictors of response to emergent therapies in paediatric immune thrombocytopenia
von: Candelaria O'Farrell, et al.
Veröffentlicht: (2025)

When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?
von: Sydney Dubois, et al.
Veröffentlicht: (2024)

Cognitive impairment among patients with chronic immune thrombocytopenia
von: David J. Kuter, et al.
Veröffentlicht: (2024)

Acute stroke in children with immune thrombocytopenia: A systematic review and meta‐analysis
von: Andrew Ly, et al.
Veröffentlicht: (2025)

Interferon‐gamma and C‐X‐C motif chemokine ligand 9, which is better for haemophagocytic lymphohistiocytosis diagnosis and monitoring?
von: Zebin Luo, et al.
Veröffentlicht: (2025)

Unveiling the responsible antigen in vaccine‐induced immune thrombotic thrombocytopenia
von: Chika Edward Uzoigwe
Veröffentlicht: (2025)

COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence
von: Hinpetch Daungsupawong, et al.
Veröffentlicht: (2024)

Longitudinal plasma proteomics in romiplostim‐treated patients with immune thrombocytopenia
von: Vivianne S. Nelson, et al.
Veröffentlicht: (2025)

Clinical decision support to aid in diagnosis of heparin‐induced thrombocytopenia
von: Tyler Gallo, et al.
Veröffentlicht: (2026)

Exploratory study on the individualized application of eltrombopag in paediatric immune thrombocytopenia guided by therapeutic drug monitoring
von: Shuyue Dong, et al.
Veröffentlicht: (2024)

Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?
von: Clara Lo
Veröffentlicht: (2024)

CD19+IL‐10+ regulatory B cells induced by IL‐12p35 regulates functional T‐cell subsets in patients with immune thrombocytopenia
von: Fanli Hua, et al.
Veröffentlicht: (2025)

Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT)
von: Vinita Dhir, et al.
Veröffentlicht: (2024)

Cytokine expression in pediatric patients with immune thrombocytopenia (ITP) in different phases of disease
von: Neeti Luke, et al.
Veröffentlicht: (2024)

Interplay of leucocyte–platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients
von: Rubén Osuna‐Gómez, et al.
Veröffentlicht: (2024)

Incidence of systemic lupus erythematosus in patients with immune thrombocytopenia: A nationwide study
von: Malin Rasmussen, et al.
Veröffentlicht: (2025)

Imaging flow cytometry as a novel approach for the diagnosis of heparin‐induced thrombocytopenia
von: Julie Carré, et al.
Veröffentlicht: (2024)

PF4 promotes CXCR3 + Tfh1 cell differentiation through STAT1 in mouse immune thrombocytopenia
von: Lei Hai, et al.
Veröffentlicht: (2025)

Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid‐resistant immune thrombocytopenia
von: Yuncui Yu, et al.
Veröffentlicht: (2025)

PF4‐associated immune thrombocytopenia and thrombosis (PITT)—More than heparin and vaccines
von: Michael Makris
Veröffentlicht: (2025)